Expression and Clinical Significance of Various Checkpoint Molecules in Advanced Osteosarcoma: Possibilities for Novel Immunotherapy

OBJECTIVES: The fact that studies on anti‐programmed cell death 1 (PD‐1) or its relevant ligand 1 (PD‐L1) have yielded such few responses greatly decreases the confidence in immunotherapy with checkpoint inhibitors for advanced osteosarcoma. We intended to characterize the expression of various chec...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lu, Chen, Chenglong, Liang, Xin, Xu, Jie, Sun, Xin, Sun, Kunkun, Yang, Rongli, Tang, Xiaodong, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977595/
https://www.ncbi.nlm.nih.gov/pubmed/36519392
http://dx.doi.org/10.1111/os.13620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977595/
https://www.ncbi.nlm.nih.gov/pubmed/36519392
http://dx.doi.org/10.1111/os.13620

Ejemplares similares